Th1/Th2 cytokine pattern in Arab children with severe asthma

Nasser M Al-Daghri1, Majed S Alokail1, Hossam M Draz2

  • 1Biomarkers Research Program, Department of Biochemistry, College of Science, King Saud University 11451, Saudi Arabia ; Prince Mutaib Chair for Biomarkers of Osteoporosis, King Saud University Riyadh, KSA.

Insights

Childhood asthma in Saudi Arabia is linked to immune system differences, with specific cytokine patterns like Interleukin-4 (IL-4) and Immunoglobulin E (IgE) playing key roles in disease development.

Area of Science:

  • Pediatric immunology
  • Respiratory medicine
  • Allergy and immunology

Background:

  • Bronchial asthma prevalence is rising in Arab countries, influenced by environmental and geographical factors.
  • Limited research exists on the immunologic underpinnings of childhood asthma in Arabic populations.
  • Understanding these immunologic factors is crucial for addressing the growing burden of pediatric asthma.

Purpose of the Study:

  • To investigate cytokine production from T cells in children with and without asthma.
  • To identify cytokine patterns associated with childhood asthma in Saudi children.
  • To elucidate the immunologic basis of asthma in this specific demographic.

Main Methods:

  • A cohort of 195 Saudi children (98 with asthma, 97 healthy controls) was recruited from the Riyadh Cohort Study.
  • Asthma diagnosis was confirmed using established pediatric criteria and medication records.
  • Cytokine levels and immunoglobulin profiles were analyzed to compare asthmatic and control groups.

Main Results:

  • Asthmatic children showed significantly reduced levels of GM-CSF, INF-γ, IL-5, IL-6, IL-8, and IgG-3 compared to controls.
  • Elevated levels of IgE, resistin, IL-4, and IgG-4 were observed in children with asthma.
  • Principal component analysis indicated IL-4, INF-γ, and IgE as critical factors in the pathogenesis of asthma in Arabic children.

Conclusions:

  • This study provides the first immunologic data on asthmatic children in Saudi Arabia.
  • Childhood asthma in this population is associated with significant immune impairment.
  • The findings highlight the role of specific cytokine patterns in asthma pathogenesis, independent of genetics and environment.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
69
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
35
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K